News
Latest news
-
7 Oct 2025
Largest ever TauPET study of Alzheimer’s deepens understanding of the disease
In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyse aggregates of tau pathology in more than 12,000 people from all over ...
-
26 Sep 2025
Meet Our Scientists Podcast: Cecilia Lundberg about the gene workshop
What if brain diseases could be cured by turning on the proper genes? Meet our scientist, Professor Cecilia Lundberg! She explains how gene therapy may complement cell therapies to...
-
19 Sep 2025
Smell test cuts need for invasive Parkinson’s screening
Early diagnosis is key to receiving proper care and advancing research on future therapies for neurodegenerative diseases such as Parkinson’s and dementia with Lewy bodies. New res...
-
16 Sep 2025
New digital cognitive test for diagnosing Alzheimer's disease
Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer's disease that is intended for use in primary care. “This digital test, w...
-
4 Sep 2025
TIME to unite lab and clinic – 1.5 million € to build an AI model of Alzheimer’s disease
Enormous amounts of data about Alzheimer’s Disease have been generated from clinical studies so far. Still, the molecular drivers of Alzheimer’s Disease are largely unknown. With t...
-
1 Sep 2025
Alzheimer’s awareness: Five research projects shaping the future of understanding, diagnosis and care
With over 15 research groups dedicated to Alzheimer’s disease research, MultiPark’s goal is to understand the origins of the disease, develop early diagnostics, and improve treatme...
-
29 Aug 2025
Why repetitive DNA matters for human brain evolution and disease
For decades, large stretches of human DNA were dismissed as ‘junk’ and considered to serve no real purpose. In a new study in Cell Genomics, researchers at Lund University in Swede...
-
1 Aug 2025
Meet Our Scientists Podcast: Niklas Mattsson-Carlgren about biomarkers and the future of Alzheimer’s
Meet our scientist, Dr. Niklas Mattsson-Carlgren! He explains why studying biomarkers is essential to advancing Alzheimer’s research.